+1.7%
HUT vs GSK
+14.9%
-13.2%
-63.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -23.2% | +5.0% | -28.3% | -20.2% |
| 7D | -29.5% | +4.9% | -34.5% | -26.7% |
| 30D | -45.2% | +9.9% | -55.1% | -41.8% |
| 3M | -51.6% | +0.2% | -51.8% | -50.0% |
| 6M | -37.3% | +2.3% | -39.6% | -35.3% |
| YTD | +6.5% | +7.1% | -0.5% | +24.0% |
| 1Y | +1.7% | +13.1% | -11.4% | +20.7% |
| All | +1.7% | +14.9% | -13.2% | +20.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling